Literature DB >> 2425780

Inhibition of murine L cell interferon action by heparin.

A Sakai, T Ebina, N Ishida.   

Abstract

Heparin added together with murine L cell interferon inhibited the development of antiviral activity in mouse L cells. When added after interferon treatment, heparin had no effect on antiviral activity. There was also no inhibition of interferon action in L cells treated with heparin before addition of interferon. On the other hand, heparin did not inhibit antiviral activities of human interferon alpha and beta. Since murine L cell interferon, but not human interferon alpha and beta, binds to a heparin affinity column and can be eluted with a solution of high salt, it is presumed that murine L cell interferon and heparin must interact with each other. The apparent interaction of heparin with murine L cell interferon was prevented by protamine, a drug that neutralizes heparin. Dextran sulfate inhibited murine L cell interferon action, but dextran and chondroitin sulfate A did not. These results suggests that heparin inhibited murine L cell interferon action by the binding via sulfate groups on its molecules. Heparin also inhibited antiviral activity of murine L cell interferon in mice infected with herpes simplex virus (+GC Miyama strain).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425780     DOI: 10.1007/bf01314146

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  Cholera toxin inhibits interferon action.

Authors:  R M Friedman; L D Kohn
Journal:  Biochem Biophys Res Commun       Date:  1976-06-21       Impact factor: 3.575

2.  Inhibition of interferon action by plant lectins.

Authors:  F Besancon; H Ankel
Journal:  Nature       Date:  1974-08-30       Impact factor: 49.962

3.  Dependence of murine sarcoma virus infection on the cell cycle.

Authors:  H Yoshikura
Journal:  J Gen Virol       Date:  1970-01       Impact factor: 3.891

Review 4.  Chemistry and pharmacology of heparin.

Authors:  J Ehrlich; S S Stivala
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

5.  High affinity binding of 125I-Labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties.

Authors:  M Aguet; B Blanchard
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

6.  Interferon induction in mice by oral administration of K-582, a new peptide antibiotic.

Authors:  A Sakai; T Ebina; N Ishida
Journal:  J Antibiot (Tokyo)       Date:  1983-03       Impact factor: 2.649

7.  High-affinity binding of 125I-labeled mouse interferon to a specific cell surface receptor. IV. Mouse gamma interferon and cholera toxin do not compete for the common receptor site of alpha / beta interferon.

Authors:  M Aguet; F Belardelli; B Blanchard; F Marcucci; I Gresser
Journal:  Virology       Date:  1982-03       Impact factor: 3.616

8.  Specific binding of human alpha interferon to a high affinity cell surface binding site on bovine kidney cells.

Authors:  K Zoon; D Zur Nedden; H Arnheiter
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

9.  Characterization of an interferon receptor on human lymphoblastoid cells.

Authors:  C R Faltynek; A A Branca; S McCandless; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.